Skip to main content
. 2017 Nov 14;8(64):107991–108005. doi: 10.18632/oncotarget.22442

Figure 4.

Figure 4

Forest plot of msSBP (A) and maSBP (B). The comparisons of LCZ696 with a control group were classified according to the dosage of LCZ696 and whether the control group was treated with olmesartan or placebo. (200 mg: treatment with LCZ696 at 200 mg daily; 400 mg: treatment with LCZ696 at 400mg daily).